October 15th, 20262026 Nobel Prize in Physiology or Medicine awarded for optogenetics discoveryThree researchers share the prize for discovering channelrhodopsin, a light-sensitive protein now being tested to restore vision in retinal disease.Read more
October 13th, 2026AAOpt 2026: Current controversies in macular hole diagnosis, managementThomas Wong, OD, FAAO, details a session he presented alongside Ronald Gentile, MD, FACS, FASRS, at AAOpt 2026.Read more
October 12th, 2026AAOpt 2026: Understanding the gene therapy landscape for retinitis pigmentosaRaman Bhakhri, OD, FAAO, alongside Xiao Yu, OD, FAAO, discussed emerging investigational therapies for the disease during their AAOpt 2026 session.Read more
October 6th, 2026AAOpt 2026: Photobiomodulation to revolutionize dry AMD treatment, Dr Rafieetary saysMohammad Rafieetary, OD, FAAO, FORS, DipABO, ABCMO, details his AAOpt 2026 presentation "Photobiomodulation in Age-Related Macular Degeneration: Evidence, Mechanisms, and Clinical Integration."Read more
October 5th, 2026AAOpt 2026: Aflibercept 8 mg extends RVO dosing as Amsler misses AMD damageAflibercept 8 mg cut RVO injections by up to 3 over 64 weeks in QUASAR, while a pair of additional posters show Amsler gaps in AMD and BRAO-linked stroke risk.Read more
October 3rd, 2026AAOpt 2026: A practical guide to pediatric retinaRaman Bhakhri, OD, FAAO, details a session given with Denise Skiadopoulos, OD, FAAO, during the annual AAOpt meeting in Anaheim, California.Read more
October 3rd, 2026AAOpt 2026: GLP-1RAs and ocular healthSherrol Reynolds, OD, FAAO, details her session "GLP-1RAs and Ocular Health: AOA Guidance for Optometric Practice 2025" during AAOpt 2026.Read more
October 19th, 2026FDA approves Brytly eye drops for ocular redness relief lasting up to 12 hoursAlcon's Brytly eye drops received FDA approval for OTC temporary relief of minor ocular redness.Read more